Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 9/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10043163 | 1.00 | OPRL1 (0.35) | OPRL1EPHX2PDE2AHCRTR1HCRTR2 | |
| SCHEMBL8771393 | 0.95 | EPHX2 (0.35) | EPHX2PDE2AKDM1ACYP2C9 | |
| SCHEMBL8771385 | 0.95 | EPHX2 (0.35) | EPHX2PDE2AKDM1ACYP2C9 | |
| SCHEMBL8771398 | 0.95 | EPHX2 (0.35) | EPHX2PDE2AKDM1ACYP2C9 | |
| SCHEMBL10043165 | 0.94 | CYP2C9 (0.36) | EPHX2PDE2AKDM1ACYP2C9 | |
| SCHEMBL23666202 | 0.91 | EPHX2 (0.35) | EPHX2PDE2AHCRTR1HCRTR2KDM1A | |
| SCHEMBL12622875 | 0.91 | OPRL1 (0.32) | OPRL1 | |
| SCHEMBL12621634 | 0.91 | OPRL1 (0.32) | OPRL1 | |
| SCHEMBL1254785 | 0.91 | OPRL1 (0.32) | OPRL1 | |
| SCHEMBL12622877 | 0.90 | OPRL1 (0.32) | OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8470199-B2 | Five-ring liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-06-25 | — | — | US | disclosed |
| US-20120074355-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120074355-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | HTR3D, KIF23, CCND3 | OPRL1 2105/4885EPHX2 2772/4885PDE2A 2748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.